Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Authors:
Open Access
- 21 July 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165, 115179
Abstract
No abstract availableKeywords
Funding Information
- Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
- Agentúra na Podporu Výskumu a Vývoja (APVV-21-0197)
- Horizon 2020 (857381/VISION)
- Horizon 2020 Framework Programme
- H2020 Spreading Excellence and Widening Participation
- European Cooperation in Science and Technology (CA21116)
- HORIZON EUROPE Framework Programme
This publication has 187 references indexed in Scilit:
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal AdenocarcinomaCancer Cell, 2014
- MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic CancerMolecular Pharmaceutics, 2014
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic CarcinomaCancer Research, 2013
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic NeoplasiaCancer Cell, 2012
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancerGut, 2012
- EZH2 couples pancreatic regeneration to neoplastic progressionGenes & Development, 2012
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Multistage nanoparticle delivery system for deep penetration into tumor tissueProceedings of the National Academy of Sciences, 2011
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005